Safety Pharmacology


Accelera is able to offer a complete "core battery" package of regulatory Safety Pharmacology studies. Employing state-of-the-art technology for data collection, analysis and storage, all studies are GLP (21 CFR part 11) compliant and designed in line with the latest regulatory guidelines.



QT liability
To assess cardiovascular/QT liabilities of new compounds while still in a discovery setting, Accelera also offers a range of in silico/in vitro/in vivo Safety Pharmacology studies.

---